Malgorzata Jaremko, Ph.D.

Founder & CEO, President | Gosia Genomics

Professional Overview

Malgorzata Jaremko is a seasoned leader and visionary in the field of clinical genetics and molecular diagnostics. As the Founder, CEO, and President of Gosia Genomics, she leverages her extensive expertise to drive innovation and elevate patient care through the development of cutting-edge genomic solutions.

Experience Summary

Current Role

As the Founder, CEO, and President of Gosia Genomics, Malgorzata is responsible for spearheading the company's strategic vision, overseeing operations, and fostering collaborative partnerships to advance the field of personalized medicine. Under her leadership, Gosia Genomics has emerged as a trailblazer, delivering transformative genetic testing and analysis services to healthcare providers and patients.

Career Progression

Prior to founding Gosia Genomics, Malgorzata held several influential roles, including Genetics Lab Director at Enzo Clinical Labs, Independent Clinical Genetics Advisor at Kindbody, and Co-Founder & Senior Executive Vice President of Clinical Lab & Molecular Diagnostics at Phosphorus. Her impressive career trajectory is marked by her pioneering work in the development and implementation of cutting-edge genomic technologies, her contributions to the advancement of the clinical genetics field, and her passionate advocacy for personalized healthcare solutions.

Academic Background

Malgorzata holds a Ph.D. in Molecular Biology from Wroclaw Medical University, where she also served as a Molecular Biology Lecturer. She has completed postdoctoral fellowships in Clinical Biochemical Genetics, Clinical Molecular Genetics, and Pharmacogenetics at the Mount Sinai School of Medicine, as well as a European Science Foundation Fellowship at Erasmus MC.

Areas of Expertise

Malgorzata's areas of expertise span clinical genetics, molecular diagnostics, pharmacogenetics, and personalized medicine. She is a recognized industry leader in the development and implementation of innovative genetic testing and analysis solutions, with a particular focus on improving patient outcomes through the integration of genomic insights into clinical decision-making.

Professional Impact

Throughout her career, Malgorzata has made significant contributions to the field of clinical genetics. As the Co-Founder and Senior Executive Vice President of Clinical Lab & Molecular Diagnostics at Phosphorus, she played a pivotal role in the company's growth and success, driving the expansion of its genetic testing portfolio and establishing it as a respected provider of personalized healthcare solutions.

Conclusion

Malgorzata Jaremko's visionary leadership, deep scientific expertise, and unwavering commitment to improving patient care position her as a trailblazer in the field of clinical genetics. As the Founder, CEO, and President of Gosia Genomics, she is poised to continue her legacy of innovation and impact, shaping the future of personalized medicine and transforming the lives of the patients and communities she serves.